Though it helps patients save money and lessens the burden of supply shortages, compounded semaglutide has generated ethical and safety issues in the medical field
These medications help you stay patient, maintain eating habit changes (this is the key, and GLP-1 medication makes this much easier to do) , and avoid frustration-driven relapses, with clinical trials showing up to 20% or higher body weight loss when combined with lifestyle changes
Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
J.ObachR
This article examines what constitutes a microdose, the rationale behind this approach, and the important safety considerations patients should discuss with their healthcare provider
Most GLP-1s are started at a low dose and then slowly increased to minimize potential side effects